UVV
UVV
Universal CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2026 | $715.24M ▼ | $72.37M ▼ | $-43.28M ▼ | -6.05% ▼ | $-1.73 ▼ | $26.1M ▼ |
| Q3-2026 | $861.29M ▲ | $77.69M ▲ | $33.25M ▼ | 3.86% ▼ | $1.33 ▼ | $93.97M ▲ |
| Q2-2026 | $754.18M ▲ | $72.18M ▼ | $34.17M ▲ | 4.53% ▲ | $1.36 ▲ | $81.46M ▲ |
| Q1-2026 | $593.76M ▼ | $80.02M ▲ | $8.5M ▼ | 1.43% ▲ | $0.34 ▼ | $52.44M ▼ |
| Q4-2025 | $702.28M | $72.14M | $9.34M | 1.33% | $0.37 | $55.65M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2026 | $62.18M ▼ | $2.77B ▼ | $1.31B ▼ | $1.42B ▼ |
| Q3-2026 | $85.23M ▼ | $3.02B ▼ | $1.49B ▼ | $1.48B ▲ |
| Q2-2026 | $88.65M ▼ | $3.07B ▼ | $1.57B ▼ | $1.47B ▲ |
| Q1-2026 | $178.44M ▼ | $3.19B ▲ | $1.69B ▲ | $1.46B ▲ |
| Q4-2025 | $260.12M | $2.99B | $1.49B | $1.46B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2026 | $-43.28M ▼ | $187.14M ▲ | $-9.25M ▲ | $-200.61M ▼ | $-23.05M ▼ | $178.61M ▲ |
| Q3-2026 | $33.25M ▼ | $114.32M ▲ | $-13.48M ▼ | $-104.3M ▲ | $-3.42M ▲ | $95.11M ▲ |
| Q2-2026 | $40.67M ▲ | $32.74M ▲ | $-8.31M ▲ | $-114.06M ▼ | $-89.78M ▼ | $23.7M ▲ |
| Q1-2026 | $8.5M ▼ | $-205.1M ▼ | $-11.91M ▼ | $134.62M ▲ | $-81.68M ▼ | $-217.16M ▼ |
| Q4-2025 | $9.34M | $158.75M | $-5.97M | $-108.07M | $45.01M | $151.03M |
Revenue by Products
| Product | Q1-2026 | Q2-2026 | Q3-2026 | Q4-2026 |
|---|---|---|---|---|
Food Ingredient Sales | $80.00M ▲ | $90.00M ▲ | $80.00M ▼ | $80.00M ▲ |
Product and Service Other | $20.00M ▲ | $10.00M ▼ | $20.00M ▲ | $70.00M ▲ |
Service Other | $30.00M ▲ | $20.00M ▼ | $40.00M ▲ | $0 ▼ |
Tobacco Sales | $460.00M ▲ | $620.00M ▲ | $720.00M ▲ | $560.00M ▼ |
Revenue by Geography
| Region | Q1-2018 | Q2-2018 | Q3-2018 | Q4-2018 |
|---|---|---|---|---|
North America | $50.00M ▲ | $60.00M ▲ | $100.00M ▲ | $100.00M ▲ |
Other Regions | $180.00M ▲ | $380.00M ▲ | $470.00M ▲ | $440.00M ▼ |
Q4 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Universal Corporation's financial evolution and strategic trajectory over the past five years.
Key positives include a long operating history and global reach, deep relationships with farmers and major tobacco manufacturers, and demonstrated ability to generate solid operating and free cash flow. The company also has a sizable equity base and retained earnings, reflecting many years of cumulative profitability, and it has begun to build an additional growth platform in plant‑based ingredients supported by process innovation and customer co‑development capabilities. Its focus on traceability and sustainability further strengthens its appeal to large, brand‑conscious customers.
The most immediate concern is the quality and consistency of the reported financial data, with zero revenue and zero assets conflicting with other metrics and making it hard to form a clean view on current performance and financial health. Even setting data issues aside, Universal bears meaningful financial risk from substantial debt and signs of a reduced cash cushion, as well as structural business risk from the long‑term decline and heavy regulation of tobacco. Execution risk in the ingredients strategy—including integrating acquisitions, managing impairments, and competing against larger ingredient players—adds another layer of uncertainty, alongside climate and geopolitical risks inherent in global agricultural sourcing.
Universal appears to be a company in transition, using longstanding strengths in agricultural sourcing and processing to diversify away from a mature, pressured tobacco market toward more promising plant‑based ingredients and sustainability‑linked solutions. The latest cash‑flow data suggest the core businesses still generate healthy cash, but the confusing income‑statement and balance‑sheet disclosures cloud visibility on profitability, liquidity, and leverage trends. Over the medium to long term, the company’s prospects will depend on how effectively it can grow and scale the ingredients segment, maintain disciplined balance‑sheet and liquidity management, and manage the gradual headwinds in tobacco while continuing to leverage its global network and operational expertise.
About Universal Corporation
https://www.universalcorp.comUniversal Corporation processes and supplies leaf tobacco and plant-based ingredients worldwide. The company operates through two segments, Tobacco Operations and Ingredients Operations. It is involved in the procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2026 | $715.24M ▼ | $72.37M ▼ | $-43.28M ▼ | -6.05% ▼ | $-1.73 ▼ | $26.1M ▼ |
| Q3-2026 | $861.29M ▲ | $77.69M ▲ | $33.25M ▼ | 3.86% ▼ | $1.33 ▼ | $93.97M ▲ |
| Q2-2026 | $754.18M ▲ | $72.18M ▼ | $34.17M ▲ | 4.53% ▲ | $1.36 ▲ | $81.46M ▲ |
| Q1-2026 | $593.76M ▼ | $80.02M ▲ | $8.5M ▼ | 1.43% ▲ | $0.34 ▼ | $52.44M ▼ |
| Q4-2025 | $702.28M | $72.14M | $9.34M | 1.33% | $0.37 | $55.65M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2026 | $62.18M ▼ | $2.77B ▼ | $1.31B ▼ | $1.42B ▼ |
| Q3-2026 | $85.23M ▼ | $3.02B ▼ | $1.49B ▼ | $1.48B ▲ |
| Q2-2026 | $88.65M ▼ | $3.07B ▼ | $1.57B ▼ | $1.47B ▲ |
| Q1-2026 | $178.44M ▼ | $3.19B ▲ | $1.69B ▲ | $1.46B ▲ |
| Q4-2025 | $260.12M | $2.99B | $1.49B | $1.46B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2026 | $-43.28M ▼ | $187.14M ▲ | $-9.25M ▲ | $-200.61M ▼ | $-23.05M ▼ | $178.61M ▲ |
| Q3-2026 | $33.25M ▼ | $114.32M ▲ | $-13.48M ▼ | $-104.3M ▲ | $-3.42M ▲ | $95.11M ▲ |
| Q2-2026 | $40.67M ▲ | $32.74M ▲ | $-8.31M ▲ | $-114.06M ▼ | $-89.78M ▼ | $23.7M ▲ |
| Q1-2026 | $8.5M ▼ | $-205.1M ▼ | $-11.91M ▼ | $134.62M ▲ | $-81.68M ▼ | $-217.16M ▼ |
| Q4-2025 | $9.34M | $158.75M | $-5.97M | $-108.07M | $45.01M | $151.03M |
Revenue by Products
| Product | Q1-2026 | Q2-2026 | Q3-2026 | Q4-2026 |
|---|---|---|---|---|
Food Ingredient Sales | $80.00M ▲ | $90.00M ▲ | $80.00M ▼ | $80.00M ▲ |
Product and Service Other | $20.00M ▲ | $10.00M ▼ | $20.00M ▲ | $70.00M ▲ |
Service Other | $30.00M ▲ | $20.00M ▼ | $40.00M ▲ | $0 ▼ |
Tobacco Sales | $460.00M ▲ | $620.00M ▲ | $720.00M ▲ | $560.00M ▼ |
Revenue by Geography
| Region | Q1-2018 | Q2-2018 | Q3-2018 | Q4-2018 |
|---|---|---|---|---|
North America | $50.00M ▲ | $60.00M ▲ | $100.00M ▲ | $100.00M ▲ |
Other Regions | $180.00M ▲ | $380.00M ▲ | $470.00M ▲ | $440.00M ▼ |
Q4 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Universal Corporation's financial evolution and strategic trajectory over the past five years.
Key positives include a long operating history and global reach, deep relationships with farmers and major tobacco manufacturers, and demonstrated ability to generate solid operating and free cash flow. The company also has a sizable equity base and retained earnings, reflecting many years of cumulative profitability, and it has begun to build an additional growth platform in plant‑based ingredients supported by process innovation and customer co‑development capabilities. Its focus on traceability and sustainability further strengthens its appeal to large, brand‑conscious customers.
The most immediate concern is the quality and consistency of the reported financial data, with zero revenue and zero assets conflicting with other metrics and making it hard to form a clean view on current performance and financial health. Even setting data issues aside, Universal bears meaningful financial risk from substantial debt and signs of a reduced cash cushion, as well as structural business risk from the long‑term decline and heavy regulation of tobacco. Execution risk in the ingredients strategy—including integrating acquisitions, managing impairments, and competing against larger ingredient players—adds another layer of uncertainty, alongside climate and geopolitical risks inherent in global agricultural sourcing.
Universal appears to be a company in transition, using longstanding strengths in agricultural sourcing and processing to diversify away from a mature, pressured tobacco market toward more promising plant‑based ingredients and sustainability‑linked solutions. The latest cash‑flow data suggest the core businesses still generate healthy cash, but the confusing income‑statement and balance‑sheet disclosures cloud visibility on profitability, liquidity, and leverage trends. Over the medium to long term, the company’s prospects will depend on how effectively it can grow and scale the ingredients segment, maintain disciplined balance‑sheet and liquidity management, and manage the gradual headwinds in tobacco while continuing to leverage its global network and operational expertise.

CEO
Preston Douglas Wigner
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1992-01-02 | Forward | 2:1 |
| 1984-03-02 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 172
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:3.81M
Value:$201.32M
BLACKROCK INC.
Shares:3.78M
Value:$199.62M
VANGUARD GROUP INC
Shares:2.98M
Value:$157.76M
Summary
Showing Top 3 of 341

